Alpha Control Liner System (ACLS)

The Alpha Control Liner System is an advanced cutaneous electrode interface for upper limb exoprosthetics, integrating sEMG sensors and signal processing electronics directly into a biocompatible, fabric-covered elastomeric gel liner. This system aims to enhance the reliability of muscle signal acquisition for pattern recognition-based prosthetic control by ensuring consistent electrode-skin contact and simplifying the prosthetic fitting process.

The Alpha Control Liner System (ACLS) is an interface solution designed for use with the Coapt Complete Control System Gen2 in upper limb exoprosthetic fittings. Its primary function is to provide the pattern recognition algorithms of the control system with muscle contraction signals from the amputee. The ACLS achieves this by integrating electronics into a fabric-covered elastomeric prosthetic liner, which non-invasively detects surface electromyography (sEMG) signals and converts them into a digital format. Key components include the Alpha Control Liner (a gel-lined user interface), the Alpha Control Module (a re-packaged EMG amplifier), a Module Cap, the Alpha Control Lock for socket suspension and connection, electrodes, and fabrication aids. This system is intended to simplify electrode placement, reduce prosthesis fabrication time for prosthetists, and improve the ease of donning and doffing for patients, ultimately facilitating control of their prosthetic devices. The ACLS represents an evolution from the EMG Interface Cable used with its predicate device, the Complete Control System Gen2. A significant design improvement is the suspension of cable pathways within a tri-block copolymer gel liner, which promotes more consistent contact between the 316L stainless steel electrodes and the user's skin due to the elastic properties of the elastomer and fabric. This liner, which directly contacts the user's skin, also incorporates electronics to convert sEMG signals to a digital format before transmission to the socket, preserving signal integrity. While the ACLS has a slightly narrower operating voltage range (5.3-16.8 VDC) and higher power consumption (115 mA at 7.4V) compared to the predicate, it has passed all requisite electrical safety (IEC 60601-1) and biocompatibility testing (ISO 10993-1, ISO 10993-5 for cytotoxicity, ISO 10993-10 for skin irritation and sensitization), along with various in-house performance validation tests ensuring its safety and effectiveness.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the tri-block copolymer gel liner's material properties specifically enhance consistent electrode-skin contact and sEMG signal quality compared to traditional electrode application methods?; What are the specific performance differences in pattern recognition accuracy and speed when using the Alpha Control Liner System versus the predicate's EMG Interface Cable with the Complete Control System Gen2?; Given the increased power consumption of the ACLS, what is the anticipated impact on the overall prosthetic system's battery life, and how does this affect daily use for amputees?; Beyond the ISO 10993 standard biocompatibility tests, what is known about the long-term wear comfort, skin breathability, and potential for microbial buildup associated with the fabric-covered elastomeric liner?; What is the learning curve and typical adjustment period for prosthetists and patients when transitioning to or initially fitting the Alpha Control Liner System, particularly concerning electrode alignment within the integrated liner?